RxDoctor Payments Data

Thaddeus Bell, MD

Family Medicine · North Charleston, SCNPI 1215974399

Payments from drug & device makers

$1,850in general payments, 2019–2025

Across 18 payments — averaging $102.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$750
  • Pfizer$263
  • Cequr Corporation$232
  • Lilly USA, LLC$144
  • GSK$114
  • Gilead$109
  • plus $239 from 6 others

What the payments were for

  • Consulting fees$75041%
  • Food & beverage$1,10059%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,850 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$36,668
Medicare patients
87
Services billed
329

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate49$52,579
TrulicityDulaglutide17$18,464
XareltoRivaroxaban15$15,046
Tresiba Flextouch U-100Insulin Degludec17$8,915
LivaloPitavastatin Calcium11$4,960
JanumetSitagliptin Phos/Metformin Hcl13$3,570
Rosuvastatin Calcium118$2,234
Amlodipine Besylate305$2,118
Nebivolol Hcl16$1,467
Ezetimibe-SimvastatinEzetimibe/Simvastatin12$1,440
Simvastatin129$1,137
Atorvastatin Calcium76$1,119
Chlorthalidone41$929
Omeprazole39$863
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide20$804

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$144$18,46417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in North Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →